This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
source: pixabay.com

This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions

  A recent article in The American Journal of Managed Care (AJMC) heralds the approval of a third CAR T-cell therapy, called Tecartus. Kite Pharma’s cell-based gene therapy is the first…

Continue Reading This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy
source: pixabay.com

Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy

According to a story from the CureDuchenne Blog, Dr. Kevin Flanigan of Nationwide Children's Hospital has recently dosed two Duchenne muscular dystrophy patients with an experimental gene therapy. This gene…

Continue Reading Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy
Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia
source: pixabay.com

Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia

  Dr. Lindsay Wilde, an oncologist at the Hematologic Malignancies Division of Jefferson University, recently contributed to an article in the Oncology Times outlining her research team’s new study and…

Continue Reading Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia
Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome
source: pixabay.com

Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome

  Researchers discovered surprising results after performing new studies of chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM). According to a report by Cort Johnson in HealthRising, the new studies give…

Continue Reading Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome
Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy
source: pixabay.com

Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy

Rare Pediatric Disease Designation has just been granted by the FDA for an investigative therapy for lymphatic malformations (LMs). This therapy is called TARA-002 and was developed by Protara Therapeutics.…

Continue Reading Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy
New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease
source: pixabay.com

New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease

  In a recent press release, biopharmaceutical company Fortress Biotech announced that their study regarding ATP7A targeted next generation DNA sequencing for Menkes disease was published in Molecular Genetics and Metabolism…

Continue Reading New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease
Three Young People With Chronic Illness Talk About the Challenges They Face
source: pixabay.com

Three Young People With Chronic Illness Talk About the Challenges They Face

  Three people with an eye on the future talk about their innermost feelings and the fact that their lives may be interrupted at any time by their chronic illness.…

Continue Reading Three Young People With Chronic Illness Talk About the Challenges They Face
Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity
source: pixabay.com

Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity

  According to data from the STOMP trial involving thirty-four patients, a triple regimen has been proven to induce durable responses in pretreated patients with relapsed/refractory multiple myeloma. A recent…

Continue Reading Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity
Rare Disease Advocacy Group has Innovative Idea to Raise Awareness Amidst Social Distancing
source: pixabay.com

Rare Disease Advocacy Group has Innovative Idea to Raise Awareness Amidst Social Distancing

Gaucher Disease Awareness Month takes place every October, but amidst this new global pandemic, planning has taken place early to figure out how to make the month as successful as…

Continue Reading Rare Disease Advocacy Group has Innovative Idea to Raise Awareness Amidst Social Distancing
The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?
source: pixabay.com

The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?

According to a story from Youth Today, the Americans with Disabilities Act (ADA) was first passed 30 years ago, in 1990. This historic law helps protect people that live with…

Continue Reading The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?
New Study Evaluates Peripheral Neuropathy Associated with Chemotherapy in Charcot-Marie-Tooth Disease Gene Variants
source: pixabay.com

New Study Evaluates Peripheral Neuropathy Associated with Chemotherapy in Charcot-Marie-Tooth Disease Gene Variants

Chemotherapy-induced peripheral neuropathy, or CIPN, is a common side effect of chemotherapy. A recent study aimed to uncover whether or not oxaliplatin chemotherapy increased risk of CIPN for those with…

Continue Reading New Study Evaluates Peripheral Neuropathy Associated with Chemotherapy in Charcot-Marie-Tooth Disease Gene Variants